<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38861513</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>11</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>6</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Prevalence and predictors of antibiotic prescription among patients hospitalized with viral lower respiratory tract infections in Southern Province, Sri Lanka.</ArticleTitle><Pagination><StartPage>e0304690</StartPage><MedlinePgn>e0304690</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0304690</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0304690</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Antimicrobial overprescription is common for lower respiratory tract infections (LRTI), as viral and bacterial infections generally present with similar clinical features. Overprescription is associated with downstream antimicrobial resistance. This study aims to identify the prevalence and predictors of antibiotic prescription among patients hospitalized with viral LRTI.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A prospective cohort study was conducted among patients aged ≥1 year hospitalized with viral LRTI in a tertiary care hospital in Southern Province, Sri Lanka from 2018-2021. Demographic, clinical, and laboratory data were recorded. Nasopharyngeal and blood samples were collected for multiplex polymerase chain reaction testing for 21 respiratory pathogens and procalcitonin (PCT) detection, respectively. Demographic and clinical features associated with antibiotic prescription were identified using Chi Square and t-tests; significant variables (p&lt;0.05) were further included in multivariable logistic regression models. The potential impact of biomarker testing on antibiotic prescription was simulated using standard c-reactive protein (CRP) and PCT cut-offs.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 1217 patients enrolled, 438 (36.0%) had ≥1 respiratory virus detected, with 48.4% of these patients being male and 30.8% children. Influenza A (39.3%) and human rhinovirus/ enterovirus (28.3%) were most commonly detected. A total of 114 (84.4%) children and 266 (87.8%) adults with respiratory viruses were treated with antibiotics. Among children, neutrophil percentage (median 63.6% vs 47.6%, p = 0.04) was positively associated with antibiotic prescription. Among adults, headache (60.6% vs 35.1%, p = 0.003), crepitations/crackles (55.3% vs 21.6%, p&lt;0.001), rhonchi/wheezing (42.9% vs 18.9%, p = 0.005), and chest x-ray opacities (27.4% vs 8.1%, p = 0.01) were associated with antibiotic prescription. Access to CRP and procalcitonin test results could have potentially decreased inappropriate antibiotic prescription in this study by 89.5% and 83.3%, respectively.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">High proportions of viral detection and antibiotic prescription were observed among a large inpatient cohort with LRTI. Increased access to point-of-care biomarker testing may improve antimicrobial prescription.</AbstractText><CopyrightInformation>Copyright: © 2024 Medrano et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Medrano</LastName><ForeName>Perla G</ForeName><Initials>PG</Initials><Identifier Source="ORCID">0000-0001-5292-5265</Identifier><AffiliationInfo><Affiliation>Duke University, Durham, North Carolina, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Duke Global Health Institute, Durham, North Carolina, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weerasinghe</LastName><ForeName>Nayani</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Ruhuna, Galle, Sri Lanka.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagahawatte</LastName><ForeName>Ajith</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Duke Global Health Institute, Durham, North Carolina, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Ruhuna, Galle, Sri Lanka.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vanderburg</LastName><ForeName>Sky</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of California, San Francisco, California, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Lawrence P</ForeName><Initials>LP</Initials><AffiliationInfo><Affiliation>Duke University, Durham, North Carolina, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Duke Global Health Institute, Durham, North Carolina, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wijayaratne</LastName><ForeName>Gaya B</ForeName><Initials>GB</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Ruhuna, Galle, Sri Lanka.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Devasiri</LastName><ForeName>Vasantha</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Ruhuna, Galle, Sri Lanka.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dilshan</LastName><ForeName>Buddhika</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Ruhuna, Galle, Sri Lanka.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sheng</LastName><ForeName>Tianchen</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Duke University, Durham, North Carolina, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Duke Global Health Institute, Durham, North Carolina, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kurukulasooriya</LastName><ForeName>Ruvini</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Ruhuna, Galle, Sri Lanka.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anderson</LastName><ForeName>Jack</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Duke University, Durham, North Carolina, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nicholson</LastName><ForeName>Bradly P</ForeName><Initials>BP</Initials><AffiliationInfo><Affiliation>Institute for Medical Research, Durham, North Carolina, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Woods</LastName><ForeName>Christopher W</ForeName><Initials>CW</Initials><AffiliationInfo><Affiliation>Duke University, Durham, North Carolina, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Duke Global Health Institute, Durham, North Carolina, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bodinayake</LastName><ForeName>Champica K</ForeName><Initials>CK</Initials><Identifier Source="ORCID">0000-0003-1339-1883</Identifier><AffiliationInfo><Affiliation>Duke Global Health Institute, Durham, North Carolina, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Ruhuna, Galle, Sri Lanka.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tillekeratne</LastName><ForeName>L Gayani</ForeName><Initials>LG</Initials><AffiliationInfo><Affiliation>Duke University, Durham, North Carolina, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Duke Global Health Institute, Durham, North Carolina, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Ruhuna, Galle, Sri Lanka.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000077740">Procalcitonin</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-41-4</RegistryNumber><NameOfSubstance UI="D002097">C-Reactive Protein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013188" MajorTopicYN="N" Type="Geographic">Sri Lanka</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="Y">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="Y">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077740" MajorTopicYN="N">Procalcitonin</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002097" MajorTopicYN="N">C-Reactive Protein</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>11</Day><Hour>18</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>11</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>11</Day><Hour>13</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38861513</ArticleId><ArticleId IdType="pmc">PMC11166322</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0304690</ArticleId><ArticleId IdType="pii">PONE-D-23-38844</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lower respiratory infections—Level 3 cause. Institute for Health Metrics and Evaluation. The Lancet; 2020. Available from: https://www.healthdata.org/results/gbd_summaries/2019/lower-respiratory-infections-level-3-cause</Citation></Reference><Reference><Citation>Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, et al.. Global Burden of 369 Diseases and Injuries in 204 Countries and territories, 1990–2019: a Systematic Analysis for the Global Burden of Disease Study 2019.
The Lancet. 2020. 
Oct
17;396(10258):1204–22. Available from: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30925-9/fulltext
doi: 10.1016/S0140-6736(20)30925-9

</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30925-9</ArticleId><ArticleId IdType="pmc">PMC7567026</ArticleId><ArticleId IdType="pubmed">33069326</ArticleId></ArticleIdList></Reference><Reference><Citation>Dasaraju PV, Liu C. Infections of the Respiratory System.
Nih.gov. University of Texas Medical Branch at Galveston; 2014. Available from: https://www.ncbi.nlm.nih.gov/books/NBK8142/</Citation><ArticleIdList><ArticleId IdType="pubmed">21413304</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, et al.. Guidelines for the management of adult lower respiratory tract infections—Full version. Clinical Microbiology and Infection [Internet]. 2011. 
Nov
26;17:E1–59. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128977/
doi: 10.1111/j.1469-0691.2011.03672.x

</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-0691.2011.03672.x</ArticleId><ArticleId IdType="pmc">PMC7128977</ArticleId><ArticleId IdType="pubmed">21951385</ArticleId></ArticleIdList></Reference><Reference><Citation>O’Brien KL, Baggett HC, Brooks WA, Feikin DR, Hammitt LL, Higdon MM, et al.. Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study. The Lancet. 2019. 
Aug;394(10200):757–79. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727070/#!po=15.0000 doi: 10.1016/S0140-6736(19)30721-4

</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)30721-4</ArticleId><ArticleId IdType="pmc">PMC6727070</ArticleId><ArticleId IdType="pubmed">31257127</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain S, Self WH, Wunderink RG, Fakhran S, Balk R, Bramley AM, et al.. Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults.
New England Journal of Medicine. 2015. 
Jul
30;373(5):415–27. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728150/
doi: 10.1056/NEJMoa1500245

</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1500245</ArticleId><ArticleId IdType="pmc">PMC4728150</ArticleId><ArticleId IdType="pubmed">26172429</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain S, Williams DJ, Arnold SR, Ampofo K, Bramley AM, Reed C, et al.. Community-Acquired Pneumonia Requiring Hospitalization among U.S. Children.
New England Journal of Medicine. 2015. 
Feb
26;372(9):835–45. Available from: https://www.nejm.org/doi/full/
doi: 10.1056/NEJMoa1405870

</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1405870</ArticleId><ArticleId IdType="pmc">PMC4697461</ArticleId><ArticleId IdType="pubmed">25714161</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray CJ. Global Burden of Bacterial Antimicrobial Resistance in 2019: A Systematic Analysis.
The Lancet. 2022. 
Jan
19;399(10325):629–55. Available from: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)02724-0/fulltext</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8841637</ArticleId><ArticleId IdType="pubmed">35065702</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheng T, Wijayaratne GB, Dabrera TM, Drew RJ, Nagahawatte A, Bodinayake CK, et al.. Point-prevalence study of antimicrobial use in public hospitals in southern Sri Lanka identifies opportunities for improving prescribing practices. Infection Control &amp; Hospital Epidemiology. 2018. Dec 7;40(2):224–7. doi: 10.1017/ice.2018.321</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/ice.2018.321</ArticleId><ArticleId IdType="pmc">PMC6353688</ArticleId><ArticleId IdType="pubmed">30522538</ArticleId></ArticleIdList></Reference><Reference><Citation>Noviello S, Huang D. The Basics and the Advancements in Diagnosis of Bacterial Lower Respiratory Tract Infections.
Diagnostics [Internet].
2019. 
Apr
3;9(2):37. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627325/
doi: 10.3390/diagnostics9020037

</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics9020037</ArticleId><ArticleId IdType="pmc">PMC6627325</ArticleId><ArticleId IdType="pubmed">30987144</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Antimicrobial resistance. Who.int. World Health Organization: WHO; 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance</Citation></Reference><Reference><Citation>Ramachandran P, Rachuri N, Martha S, Shakthivel R, Gundala A, Battu T. Implications of Overprescription of Antibiotics: A Cross-Sectional Study.
Journal of Pharmacy And Bioallied Sciences. 2019;11(6):434. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555336/
doi: 10.4103/JPBS.JPBS_62_19

</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/JPBS.JPBS_62_19</ArticleId><ArticleId IdType="pmc">PMC6555336</ArticleId><ArticleId IdType="pubmed">31198382</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijnands GJA. Diagnosis and interventions in lower respiratory tract infections. The American Journal of Medicine [Internet]. 1992. 
Apr
6;92(4):S91–7. Available from: https://www.amjmed.com/article/0002-9343(92)90317-5/abstract
doi: 10.1016/0002-9343(92)90317-5

</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9343(92)90317-5</ArticleId><ArticleId IdType="pubmed">1580272</ArticleId></ArticleIdList></Reference><Reference><Citation>Carroll KC. Laboratory Diagnosis of Lower Respiratory Tract Infections: Controversy and Conundrums. Journal of Clinical Microbiology [Internet]. 2002. 
Sep
1;40(9):3115–20. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC130746/
doi: 10.1128/JCM.40.9.3115-3120.2002

</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.40.9.3115-3120.2002</ArticleId><ArticleId IdType="pmc">PMC130746</ArticleId><ArticleId IdType="pubmed">12202540</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanderburg S, Wijayaratne G, Danthanarayana N, Jayamaha J, Piyasiri B, Halloluwa C, et al.. Outbreak of severe acute respiratory infection in Southern Province, Sri Lanka in 2018: a cross-sectional study. BMJ Open. 2020. Nov;10(11):e040612. doi: 10.1136/bmjopen-2020-040612</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-040612</ArticleId><ArticleId IdType="pmc">PMC7651749</ArticleId><ArticleId IdType="pubmed">33158834</ArticleId></ArticleIdList></Reference><Reference><Citation>Nirubaa U. Burden of respiratory disease on hospital admission of children: Experience from a tertiary care centre. Sri Lanka Journal of Child Health. 2021. Dec 5;50(4):661.</Citation></Reference><Reference><Citation>Zhang HL, Bodinayake C, Wijayaratne GB, Jayatissa P, Piyasiri DLB, Kurukulasooriya R, et al.. Point-prevalence survey of outpatient antibiotic prescription at a tertiary medical center in Sri Lanka: opportunities to improve prescribing practices for respiratory illnesses.
BMC Infectious Diseases. 2021. 
Jan 21 [cited 2023 Aug 25];21:97. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818802/
doi: 10.1186/s12879-021-05804-6

</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-021-05804-6</ArticleId><ArticleId IdType="pmc">PMC7818802</ArticleId><ArticleId IdType="pubmed">33478430</ArticleId></ArticleIdList></Reference><Reference><Citation>NxTAG® Respiratory Pathogen Panel Test | Diasorin [Internet]. int.diasorin.com. DiaSorin; Available from: https://int.diasorin.com/en/molecular-diagnostics/kits-reagents/nxtag-respiratory-pathogen-panel</Citation></Reference><Reference><Citation>NxTAG ® Respiratory Pathogen Panel + SARS-CoV-2 Package Insert [Internet]. Luminex Corporation. U.S. Food and Drug Administration; 2022 Nov. Available from: https://www.fda.gov/media/146495/download</Citation></Reference><Reference><Citation>Lee CK, Lee HK, Ng CWS, Chiu L, Tang JWT, Loh TP, et al.. Comparison of Luminex NxTAG Respiratory Pathogen Panel and xTAG Respiratory Viral Panel FAST Version 2 for the Detection of Respiratory Viruses. Annals of Laboratory Medicine [Internet]. 2017;37(3):267. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5339100/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5339100</ArticleId><ArticleId IdType="pubmed">28224774</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonsalves S, Mahony J, Rao A, Dunbar S, Juretschko S. Multiplexed detection and identification of respiratory pathogens using the NxTAG® respiratory pathogen panel.
Methods [Internet].
2019. 
Apr
1;158:61–8. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128802/
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7128802</ArticleId><ArticleId IdType="pubmed">30660863</ArticleId></ArticleIdList></Reference><Reference><Citation>Popowitch EB, Kaplan S, Wu Z, Tang YW, Miller MB. Comparative Performance of the Luminex NxTAG Respiratory Pathogen Panel, GenMark eSensor Respiratory Viral Panel, and BioFire FilmArray Respiratory Panel.
Mostafa HH, editor. Microbiology Spectrum [Internet]. 2022. 
Jun
29; Available from: https://journals.asm.org/doi/
doi: 10.1128/spectrum.01248-22

</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.01248-22</ArticleId><ArticleId IdType="pmc">PMC9431521</ArticleId><ArticleId IdType="pubmed">35766513</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng L, Li Z, Zhao S, Nair H, Flaxman S, Xu W, et al.. Viral Etiologies of Hospitalized Acute Lower Respiratory Infection Patients in China, 2009–2013. PLOS ONE. 2014 Jun 19;9(6):e99419–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4063718</ArticleId><ArticleId IdType="pubmed">24945280</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulpuru S, Aaron SD, Ronksley PE, Lawrence N, Forster AJ. Hospital Resource Utilization and Patient Outcomes Associated with Respiratory Viral Testing in Hospitalized Patients. Emerging Infectious Diseases. 2015. Aug;21(8):1366–71. doi: 10.3201/eid2108.140978</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2108.140978</ArticleId><ArticleId IdType="pmc">PMC4517710</ArticleId><ArticleId IdType="pubmed">26197268</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC. Causes of Pneumonia. CDC. 2019. Available from: https://www.cdc.gov/pneumonia/causes.html</Citation></Reference><Reference><Citation>Viral pneumonia Information | Mount Sinai—New York. Mount Sinai Health System. Available from: https://www.mountsinai.org/health-library/diseases-conditions/viral-pneumonia</Citation></Reference><Reference><Citation>Ruuskanen O, Lahti E, Jennings LC, Murdoch DR. Viral pneumonia.
Lancet (London, England).
2011;377(9773):1264–75. Available from: https://www.ncbi.nlm.nih.gov/pubmed/21435708/
doi: 10.1016/S0140-6736(10)61459-6

</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61459-6</ArticleId><ArticleId IdType="pmc">PMC7138033</ArticleId><ArticleId IdType="pubmed">21435708</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeman AM, Soman-Faulkner K, L Jr. Viral Pneumonia. Nih.gov. StatPearls Publishing; 2019. Available from: https://www.ncbi.nlm.nih.gov/books/NBK513286/</Citation></Reference><Reference><Citation>van Houten CB, Cohen A, Engelhard D, Hays JP, Karlsson R, Moore E, et al.. Antibiotic misuse in respiratory tract infections in children and adults—a prospective, multicentre study (TAILORED Treatment). European Journal of Clinical Microbiology &amp; Infectious Diseases. 2019. Feb 1;38(3):505–14. doi: 10.1007/s10096-018-03454-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-018-03454-2</ArticleId><ArticleId IdType="pmc">PMC6394715</ArticleId><ArticleId IdType="pubmed">30707378</ArticleId></ArticleIdList></Reference><Reference><Citation>Saliba-Gustafsson EA, Dunberger Hampton A, Zarb P, Orsini N, Borg MA, Stålsby Lundborg C. Factors associated with antibiotic prescribing in patients with acute respiratory tract complaints in Malta: a 1-year repeated cross-sectional surveillance study. BMJ Open. 2019. Dec;9(12):e032704. doi: 10.1136/bmjopen-2019-032704</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2019-032704</ArticleId><ArticleId IdType="pmc">PMC6937012</ArticleId><ArticleId IdType="pubmed">31857311</ArticleId></ArticleIdList></Reference><Reference><Citation>Strumiło J, Chlabicz S, Pytel-Krolczuk B, Marcinowicz L, Rogowska-Szadkowska D, Milewska AJ. Combined assessment of clinical and patient factors on doctors’ decisions to prescribe antibiotics.
BMC family practice.
2016. 
Jun
3 [cited 2020 Sep 7];17:63. Available from: https://pubmed.ncbi.nlm.nih.gov/27255505/
doi: 10.1186/s12875-016-0463-6

</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12875-016-0463-6</ArticleId><ArticleId IdType="pmc">PMC4891944</ArticleId><ArticleId IdType="pubmed">27255505</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopstaken RM, Butler CC, Muris JWM, Knottnerus JA, Kester ADM, Rinkens PELM, et al.. Do clinical findings in lower respiratory tract infection help general practitioners prescribe antibiotics appropriately? An observational cohort study in general practice. Family Practice.
2005. 
Dec
2;23(2):180–7. Available from: https://academic.oup.com/fampra/article/23/2/180/527307
doi: 10.1093/fampra/cmi100

</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/fampra/cmi100</ArticleId><ArticleId IdType="pubmed">16326800</ArticleId></ArticleIdList></Reference><Reference><Citation>Seaton RA, Cooper L, Gibbons CL, Malcolm W, Choo-Kang B, Griffith D, et al.. Antibiotic prescribing for respiratory tract infection in patients with suspected and proven COVID-19: results from an antibiotic point prevalence survey in Scottish hospitals. JAC Antimicrob Resist. 2021. Jun 18;3(2):dlab078. doi: 10.1093/jacamr/dlab078 ; PMCID: PMC8211567.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jacamr/dlab078</ArticleId><ArticleId IdType="pmc">PMC8211567</ArticleId><ArticleId IdType="pubmed">34223137</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhee C, Mansour MK. UpToDate. UpToDate. 2022 Nov 3; Available from: https://www.uptodate.com/contents/procalcitonin-use-in-lower-respiratory-tract-infections</Citation></Reference><Reference><Citation>Schuetz P, Wirz Y, Sager R, Christ-Crain M, Stolz D, Tamm M, et al.. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database of Systematic Reviews. 2017. Oct 12;(10).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6485408</ArticleId><ArticleId IdType="pubmed">29025194</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuetz P, Christ-Crain M, Thomann R, Falconnier C, Wolbers M, Widmer I, et al.. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA. 2009. 
Sep
9;302(10):1059–66. Available from: https://www.ncbi.nlm.nih.gov/pubmed/19738090
doi: 10.1001/jama.2009.1297

</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2009.1297</ArticleId><ArticleId IdType="pubmed">19738090</ArticleId></ArticleIdList></Reference><Reference><Citation>Kristoffersen KB, Søgaard OS, Wejse C, Black FT, Greve T, Tarp B, et al.. Antibiotic treatment interruption of suspected lower respiratory tract infections based on a single procalcitonin measurement at hospital admission—a randomized trial. Clinical Microbiology and Infection. 2009. May;15(5):481–7. doi: 10.1111/j.1469-0691.2009.02709.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-0691.2009.02709.x</ArticleId><ArticleId IdType="pubmed">19416298</ArticleId></ArticleIdList></Reference><Reference><Citation>Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, et al.. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. The Lancet. 2004. Feb;363(9409):600–7. doi: 10.1016/S0140-6736(04)15591-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(04)15591-8</ArticleId><ArticleId IdType="pubmed">14987884</ArticleId></ArticleIdList></Reference><Reference><Citation>Nora D, Salluh J, Martin-Loeches I, Póvoa P. Biomarker-guided antibiotic therapy—strengths and limitations. Annals of Translational Medicine. 2017. May;5(10):208–8. doi: 10.21037/atm.2017.04.04</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/atm.2017.04.04</ArticleId><ArticleId IdType="pmc">PMC5451622</ArticleId><ArticleId IdType="pubmed">28603723</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee C, Kwa A, Apisarnthanarak A, Feng J, Gluck E, Ito A, et al.. Procalcitonin (PCT)-guided antibiotic stewardship in Asia-Pacific countries: adaptation based on an expert consensus meeting. Clinical Chemistry and Laboratory Medicine (CCLM). 2020;58(12): 1983–1991. doi: 10.1515/cclm-2019-1122</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2019-1122</ArticleId><ArticleId IdType="pubmed">31926074</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung GW, Wu JE, Yeo CL, Chan D, Hsu LY. Antimicrobial stewardship.
Virulence.
2013. 
Feb
15;4(2):151–7. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654615/
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3654615</ArticleId><ArticleId IdType="pubmed">23302793</ArticleId></ArticleIdList></Reference><Reference><Citation>de Carvalho FRT, Telles JP, Tuon FFB, Rabello Filho R, Caruso P, Correa TD. Antimicrobial Stewardship Programs: A Review of Strategies to Avoid Polymyxins and Carbapenems Misuse in Low Middle-Income Countries. Antibiotics. 2022. Mar 12;11(3):378. doi: 10.3390/antibiotics11030378</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics11030378</ArticleId><ArticleId IdType="pmc">PMC8944697</ArticleId><ArticleId IdType="pubmed">35326841</ArticleId></ArticleIdList></Reference><Reference><Citation>Rolfe R, Kwobah C, Muro F, Ruwanpathirana A, Lyamuya F, Bodinayake C, et al.. Barriers to implementing antimicrobial stewardship programs in three low- and middle-income country tertiary care settings: findings from a multi-site qualitative study. Antimicrobial Resistance &amp; Infection Control. 2021. Mar 25;10(1). doi: 10.1186/s13756-021-00929-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13756-021-00929-4</ArticleId><ArticleId IdType="pmc">PMC7993456</ArticleId><ArticleId IdType="pubmed">33766135</ArticleId></ArticleIdList></Reference><Reference><Citation>van Griensven J, Cnops L, De Weggheleire A, Declercq S, Bottieau E. Point-of-Care Biomarkers to Guide Antibiotic Prescription for Acute Febrile Illness in Sub-Saharan Africa: Promises and Caveats. Open Forum Infect Dis. 2020. Jun 30;7(8):ofaa260. doi: 10.1093/ofid/ofaa260 ; PMCID: PMC7423291.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofaa260</ArticleId><ArticleId IdType="pmc">PMC7423291</ArticleId><ArticleId IdType="pubmed">32818139</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouzid D, Le Hingrat Q, Salipante F, Ferré V, Chevallier T, Tubiana S, et al.. Agreement of respiratory viruses’ detection between nasopharyngeal swab and bronchoalveolar lavage in adults admitted for pneumonia: a retrospective study. Clinical Microbiology and Infection [Internet]. 2023. 
Jul
1;29(7):942.e1–6. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873593/
doi: 10.1016/j.cmi.2022.12.024

</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.12.024</ArticleId><ArticleId IdType="pmc">PMC9873593</ArticleId><ArticleId IdType="pubmed">36708772</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulrich P, Chen D. 1332. Clinical Indicators for When Bronchoalveolar Lavage (BAL) Is Needed Beyond Nasopharyngeal Swab (NP) Testing for Viral Respiratory Infections. Open Forum Infectious Diseases [Internet]. 2021 Nov 1;8(Supplement_1):S754–4. Available from: https://academic.oup.com/ofid/article/8/Supplement_1/S754/6451045</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>